Fast Dissolve Oral Dosing of Macromolecules
Catalent's Zydis® orally disintegrating tablet (ODT) fast-dissolve formulation is a unique, freeze-dried oral dosage form that disperses instantly in the mouth, requiring no water.
With more than 20 products launched in 50 countries, Zydis is the world's best in class ODT technology. Whether to advance pharmacokinetics through pre-gastric absorption, potentially improve patient compliance, or add marketing advantage to a valued brand, Catalent's customers draw on Zydis fast dissolve technology to potentially enhance investment value and accelerate a product's potential.
Catalent has now expanded the Zydis technology platform to overcome traditional oral delivery challenges of large molecules such as proteins, peptides, viral vaccines and allergens. Zydis Bio has the potential to deliver fast-dissolve formulations of such therapies in a patient preferred oral fast dissolve dose form, in as little as three seconds.
Catalent. more products. better treatments. reliably suppliedâ¢
Contact Details :
Catalent Pharma Solutions
Website: www.catalent.com
E-mail: solutions@catalent.com
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
